Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Twenty-two innovations awarded 'Delivering a Net Zero NHS' competition in England

On May 3, 2024, the Small Business Research Initiative (SBRI) Healthcare, funded by NHS Accelerated Access Collaborative, awarded £3.2 million to 22 innovations to improve patient care and save money while making the NHS greener. These include projects to explore the decontamination and recycling of single-use plastics, the use of at-home finger prick blood tests, and health apps. Some examples of awarded innovations are provided below:

  • Rewire (Rewire Rehab), a neurorehabilitation app, to reduce the carbon footprint of a community stroke rehabilitation service;
  • The use of at-home finger prick blood tests for prostate cancer patients (Royal Devon University Healthcare NHS Foundation Trust);
  • Path Active (Walk With Path) - a sensor-rich haptic wearable and advanced telemedicine platform to prevent diabetic foot ulcers and reduce carbon footprint.

See the full details here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.